Hepatitis C in HIV-infected patients - Therapeutic approach

Clinical Microbiology and Infection

Volumn 8, Issue 2, 2002, Pages 80-84

  Fernandez I ^a   Rubio, R ^a   Lumbreras, C ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Hepatitis C; HIV; Therapy

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT; GUANOSINE DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; PROTEINASE INHIBITOR; RIBAVIRIN; STAVUDINE; ZIDOVUDINE;

ANOREXIA; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE COURSE; DRUG RESPONSE; FATIGUE; FLU LIKE SYNDROME; HEADACHE; HELPER CELL; HEMOLYTIC ANEMIA; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFESPAN; LIVER DISEASE; LIVER FAILURE; LIVER TOXICITY; LIVER TRANSPLANTATION; LYMPHOCYTE COUNT; MYALGIA; NEUTROPENIA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SUPERINFECTION; THROMBOCYTOPENIA; VIRUS LOAD;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; STAPHYLOCOCCUS PHAGE 3A;

EID: 0036462863     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1198-743x.2001.00395.x     Document Type: Review

References (39)

1. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users
2. Impact of chronic liver disease due to hepatitis viruses as a cause of hospital admission and death in HIV-infected drug users
3. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis
4. Human immunodeficiency virus infection modifies the natural history of chronic parenterally acquired hepatitis C with an unusually rapid progression to cirrhosis
5. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C
6. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus co-infected patients
7. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' organisation
8. The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users
9. Hepatitis C virus (HCV) genotype does not appear to be a significant prognostic factor in HIV-HCV-coinfected patients
10. The natural history of chronic hepatitis C in haemophiliacs
11. The progression of HCV-associated liver disease in a cohort of haemophilic patients
12. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus USPHS/IDSA
13. Recombinant interferon-alfa for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus
14. Treatment with recombinant alfa-interferon of chronic hepatitis C in anti-HIV-positive patients
15. Treatment of chronic hepatitis C with interferon-alfa in patients infected with the human immunodeficiency virus
16. Interferon alfa for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus
17. Interferon alpha treatment of chronic hepatitis C in HIV-infected patients receiving zidovudine: Efficacy, tolerance and response related factors
18. Does HIV-infection influence the response of chronic hepatitis C to interferon treatment? A French multicenter prospective study
19. A pilot study on the efficacy of escalating dosage of alpha-interferon for chronic hepatitis C in anti-HIV positive patients
20. Rapid decline of CD+ cells after IFN-α treatment in HIV-1 infection
21. Opportunistic infections and CD4 lymphocytopenia with interferon treatment in HIV-1-infected patients
22. CD4+ T-lymphocytopenia in HIV-infected patients receiving interferon therapy for chronic hepatitis C
23. Randomised, double-blind, placebo-controlled trial of interferon α2b with and without ribavirin for chronic hepatitis C
24. Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: An early report
25. Interferon plus ribavirin in HIV-infected patients with chronic hepatitis C
26. Efficacy and safety of combination therapy with interferon-alpha2b and ribavirin for chronic hepatitis C in HIV-infected patients
27. Ribavirin therapy for chronic hepatitis C does not modify HIV viral load in HIV-1 positive patients under antiretroviral treatment
28. A randomized trial of ribavirin and interferon-α vs. interferon-α alone in patients with chronic hepatitis C who were non-responders to a previous treatment
29. Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection
30. Effect of ribavirin on zidovudine efficacy and toxicity in vitro: A concentration-dependent interaction
31. A phase 1 study of ribavirin in human immunodeficiency virus-infected patients
32. Hepatotoxicity after introduction of highly active antiretroviral therapy
33. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis
34. Transplantation in HIV+ patients
35. An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1
36. Liver transplantation for an HIV-positive patient in the era of highly active antiretroviral therapy
37. Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome
38. Solid organ transplantation in patients with HIV infection
39. Trasplante hepático en pacientes infectados por el virus de la inmunodeficiencia humana: El difícil reto de una nueva etapa